Karyopharm Therapeutics Announces Appointment of Paul Brannelly as Senior Vice President of Finance and Administration

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NATICK, Mass., June 13, 2013 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc., a leader in the new field of nuclear transport modulators, today announced that Paul Brannelly has joined the company as Senior Vice President, Finance and Administration. Mr. Brannelly brings over 13 years of experience in senior management roles leading growth-oriented biopharmaceutical companies through private and public financings, mergers and acquisitions and general financial operations. In this role at Karyopharm, Mr. Brannelly will be responsible for leading and managing all of the company's finance activities and will be a member of the management team.

Help employers find you! Check out all the jobs and post your resume.

Back to news